肺部药物递送的装置与制剂技术进展
Advances in device and formulation technologies for pulmonary drug delivery.
作者信息
Chan John Gar Yan, Wong Jennifer, Zhou Qi Tony, Leung Sharon Shui Yee, Chan Hak-Kim
机构信息
Respiratory Technology, Woolcock Institute of Medical Research and Discipline of Pharmacology, Sydney Medical School, The University of Sydney, Sydney, 2037, NSW, Australia.
出版信息
AAPS PharmSciTech. 2014 Aug;15(4):882-97. doi: 10.1208/s12249-014-0114-y. Epub 2014 Apr 12.
Abstract
Inhaled pharmaceuticals are formulated and delivered differently according to the therapeutic indication. However, specific device-formulation coupling is often fickle, and new medications or indications also demand new strategies. The discontinuation of chlorofluorocarbon propellants has seen replacement of older metered dose inhalers with dry powder inhaler formulations. High-dose dry powder inhalers are increasingly seen as an alternative dosage form for nebulised medications. In other cases, new medications have completely bypassed conventional inhalers and been formulated for use with unique inhalers such as the Staccato® device. Among these different devices, integration of software and electronic assistance has become a shared trend. This review covers recent device and formulation advances that are forming the current landscape of inhaled therapeutics.
摘要
吸入式药物根据治疗适应症的不同而采用不同的配方和给药方式。然而，特定的装置与配方的搭配往往不稳定，新药物或新适应症也需要新的策略。随着氯氟烃推进剂的停用，旧的定量吸入器已被干粉吸入器配方所取代。高剂量干粉吸入器越来越被视为雾化药物的替代剂型。在其他情况下，新药物完全绕过了传统吸入器，采用了如Staccato®装置等独特吸入器的配方。在这些不同的装置中，软件与电子辅助的整合已成为一个共同趋势。本综述涵盖了构成当前吸入治疗格局的近期装置和配方进展。
相似文献
1
Advances in device and formulation technologies for pulmonary drug delivery.肺部药物递送的装置与制剂技术进展
AAPS PharmSciTech. 2014 Aug;15(4):882-97. doi: 10.1208/s12249-014-0114-y. Epub 2014 Apr 12.
2
A review of co-milling techniques for the production of high dose dry powder inhaler formulation.用于生产高剂量干粉吸入剂制剂的共研磨技术综述。
Drug Dev Ind Pharm. 2017 Aug;43(8):1229-1238. doi: 10.1080/03639045.2017.1313858. Epub 2017 Apr 19.
3
Powder Production and Particle Engineering for Dry Powder Inhaler Formulations.干粉吸入剂制剂的粉末生产与颗粒工程
Curr Pharm Des. 2015;21(27):3902-16. doi: 10.2174/1381612821666150820111134.
4
Aerodynamic factors responsible for the deaggregation of carrier-free drug powders to form micrometer and submicrometer aerosols.载药粉末解聚形成微米和亚微米气溶胶的空气动力学因素。
Pharm Res. 2013 Jun;30(6):1608-27. doi: 10.1007/s11095-013-1001-z. Epub 2013 Mar 8.
5
Assessment of nicotine release from nicotine-loaded chitosan nanoparticles dry powder inhaler formulations via locomotor activity of C57BL/6 mice.通过 C57BL/6 小鼠的运动活性评估载尼古丁壳聚糖纳米粒子干粉吸入剂制剂中尼古丁的释放情况。
Eur J Pharm Biopharm. 2020 Sep;154:175-185. doi: 10.1016/j.ejpb.2020.07.011. Epub 2020 Jul 16.
6
The nanoscale in pulmonary delivery. Part 2: formulation platforms.肺部给药中的纳米尺度。第2部分：制剂平台。
Expert Opin Drug Deliv. 2007 Nov;4(6):607-20. doi: 10.1517/17425247.4.6.607.
7
How can we bring high drug doses to the lung?我们如何将高剂量药物递送到肺部？
Eur J Pharm Biopharm. 2014 Jan;86(1):1-6. doi: 10.1016/j.ejpb.2013.11.005. Epub 2013 Dec 1.
8
Technological and practical challenges of dry powder inhalers and formulations.干粉吸入器及其制剂的技术和实际挑战。
Adv Drug Deliv Rev. 2014 Aug;75:18-31. doi: 10.1016/j.addr.2014.04.004. Epub 2014 Apr 13.
9
Alternative carriers in dry powder inhaler formulations.干粉吸入剂配方中的替代载体。
Drug Discov Today. 2014 May;19(5):618-26. doi: 10.1016/j.drudis.2013.11.013. Epub 2013 Nov 21.
10
In vitro and in vivo performance of dry powder inhalation formulations: comparison of particles prepared by thin film freezing and micronization.干粉吸入制剂的体外和体内性能：薄膜冷冻法与微粉化法制备颗粒的比较
AAPS PharmSciTech. 2014 Aug;15(4):981-93. doi: 10.1208/s12249-014-0126-7. Epub 2014 May 14.
引用本文的文献
1
Inhalation Dosage Forms: A Focus on Dry Powder Inhalers and Their Advancements.吸入剂型：聚焦干粉吸入器及其进展
Pharmaceuticals (Basel). 2023 Nov 28;16(12):1658. doi: 10.3390/ph16121658.
2
Amorphous Drug Nanoparticles for Inhalation Therapy of Multidrug-Resistant Tuberculosis.用于治疗耐多药结核病的无定形药物纳米颗粒。
ACS Nano. 2023 May 23;17(10):9478-9486. doi: 10.1021/acsnano.3c01664. Epub 2023 May 9.
3
Feedback systems in multi-dose dry powder inhalers.多剂量干粉吸入器中的反馈系统。
Postepy Dermatol Alergol. 2023 Feb;40(1):16-21. doi: 10.5114/ada.2022.117039. Epub 2022 Jun 8.
4
Tadalafil Nanoemulsion Mists for Treatment of Pediatric Pulmonary Hypertension via Nebulization.用于雾化治疗小儿肺动脉高压的他达拉非纳米乳雾剂
Pharmaceutics. 2022 Dec 5;14(12):2717. doi: 10.3390/pharmaceutics14122717.
5
Spray Dried Rugose Lipid Particle Platform for Respiratory Drug Delivery.喷雾干燥的皱缩脂质颗粒给药平台用于呼吸道药物输送。
Pharm Res. 2022 Apr;39(4):805-823. doi: 10.1007/s11095-022-03242-w. Epub 2022 Apr 1.
6
The future of dry powder inhaled therapy: Promising or discouraging for systemic disorders?干粉吸入疗法的未来：对全身疾病是有希望还是令人沮丧？
Int J Pharm. 2022 Feb 25;614:121457. doi: 10.1016/j.ijpharm.2022.121457. Epub 2022 Jan 10.
7
Dry Powder Inhalers in the Digitalization Era: Current Status and Future Perspectives.数字化时代的干粉吸入器：现状与未来展望
Pharmaceutics. 2021 Sep 12;13(9):1455. doi: 10.3390/pharmaceutics13091455.
8
Engineering Preclinical Tools and Therapeutics to Understand and Treat COVID-19.构建临床前工具和疗法以了解和治疗新型冠状病毒肺炎
Dela J Public Health. 2020 Jul 1;6(2):32-35. doi: 10.32481/djph.2020.07.009. eCollection 2020 Jul.
9
Design and Characterizations of Inhalable Poly(lactic--glycolic acid) Microspheres Prepared by the Fine Droplet Drying Process for a Sustained Effect of Salmon Calcitonin.可吸入性聚（乳酸-乙醇酸）微球的设计与特性研究，该微球由细乳液干燥工艺制备，用于鲑鱼降钙素的持续作用。
Molecules. 2020 Mar 13;25(6):1311. doi: 10.3390/molecules25061311.
10
Improving the Efficiency of Respiratory Drug Delivery: A Review of Current Treatment Trends and Future Strategies for Asthma and Chronic Obstructive Pulmonary Disease.提高呼吸道药物递送效率：哮喘和慢性阻塞性肺疾病当前治疗趋势及未来策略综述
Pulm Ther. 2017 Dec;3(2):267-281. doi: 10.1007/s41030-017-0046-2. Epub 2017 Jun 27.
本文引用的文献
1
New poly(lactic-co-glycolic acid) derivatives: Modular polymers with tailored properties.新型聚乳酸-乙醇酸共聚物衍生物：具有定制特性的模块化聚合物。
Drug Discov Today Technol. 2005 Spring;2(1):7-13. doi: 10.1016/j.ddtec.2005.05.017.
2
Advances in metered dose inhaler technology: formulation development.定量吸入器技术进展：制剂研发
AAPS PharmSciTech. 2014 Apr;15(2):434-55. doi: 10.1208/s12249-013-0063-x. Epub 2014 Jan 23.
3
Advances in metered dose inhaler technology: hardware development.定量吸入器技术进展：硬件开发
AAPS PharmSciTech. 2014 Apr;15(2):326-38. doi: 10.1208/s12249-013-0062-y. Epub 2013 Dec 20.
4
Comparing usability of NEXThaler(®) with other inhaled corticosteroid/long-acting β2-agonist fixed combination dry powder inhalers in asthma patients.比较 Nexthaler（®）与其他吸入性皮质类固醇/长效β2-激动剂固定剂量干粉吸入器在哮喘患者中的使用情况。
J Aerosol Med Pulm Drug Deliv. 2014 Oct;27(5):363-70. doi: 10.1089/jamp.2013.1086. Epub 2013 Dec 3.
5
On the correlation of output rate and aerodynamic characteristics in vibrating-mesh-based aqueous aerosol delivery.基于振动筛网的水性气雾剂递送中输出速率与空气动力学特性的相关性
Int J Pharm. 2014 Jan 30;461(1-2):34-7. doi: 10.1016/j.ijpharm.2013.11.036. Epub 2013 Nov 26.
6
The effects of suspension particle size on the performance of air-jet, ultrasonic and vibrating-mesh nebulisers.悬浮颗粒大小对空气喷射式、超声式和振动筛网式雾化器性能的影响。
Int J Pharm. 2014 Jan 30;461(1-2):234-41. doi: 10.1016/j.ijpharm.2013.11.022. Epub 2013 Nov 22.
7
Inhaled antibiotics to treat lung infection.吸入性抗生素用于治疗肺部感染。
Pharm Pat Anal. 2013 Sep;2(5):647-63. doi: 10.4155/ppa.13.47.
8
More than just reassurance on tiotropium safety.不仅仅是关于噻托溴铵安全性的保证。
N Engl J Med. 2013 Oct 17;369(16):1555-6. doi: 10.1056/NEJMe1310107. Epub 2013 Sep 8.
9
Synergistic antibiotic combination powders of colistin and rifampicin provide high aerosolization efficiency and moisture protection.黏菌素和利福平的协同抗生素组合粉末具有高气雾化效率和防潮性能。
AAPS J. 2014 Jan;16(1):37-47. doi: 10.1208/s12248-013-9537-8. Epub 2013 Oct 16.
Zotero 插件